European EGPA Study Group
1 clinical trials · Sponsor
◉ Watch European EGPA Study Group
| Record | Firm | Date |
|---|---|---|
| Long-Term Safety and Effectiveness of Mepolizumab 300 mg in Europe (Mepo LTF Study) (NCT07591753) | European EGPA Study Group | 2025-09-18 |
Track European EGPA Study Group automatically
Every clearance here is in the API, with alerts when new ones post.